Discontinued Operations - Summary of Significant Noncash Items and Cash Paid for Capital Expenditures of Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and amortization	$ 0	$ 35,731	$ 46,950
Goodwill impairment of discontinued operations	0	146,757	0
Amortization of debt issuance costs and discount	1,381	15,692	4,789
Discontinued Operations, Disposed of by Sale | Life Sciences
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and amortization		35,731	46,950
Goodwill impairment of discontinued operations	0	146,757	0
Amortization of debt issuance costs and discount		13,990	3,368
Loss on extinguishment of debt and write-off of debt issuance costs	$ 0	1,388	2,753
Acquisition of property, plant and equipment		8,416	21,834
Right-of-use assets obtained in exchange for new finance lease liabilities		695	5,321
Right-of-use assets obtained in exchange for new operating lease liabilities		$ 6,174	$ 51